Xinnuowei: Announcement on the completion of the general election of the board of directors and the appointment of senior managers and securities affairs representatives
Securities code: 300765 Securities abbreviation: Xinnuowei Announcement number: 2026-045
CSPC Innovative Pharmaceutical Co., Ltd.
Regarding the completion of the general election of the Board of Directors and the appointment of senior management personnel
Announcements from and Securities Representatives
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
CSPC Pharmaceutical Innovation Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the second extraordinary shareholders' meeting of 2026 on May 14, 2026, and reviewed and approved the "Proposal on the General Election of the Company's Board of Directors and the Election of Non-Independent Directors of the Seventh Board of Directors" and the "Proposal on the General Election of the Company's Board of Directors and the Election of Independent Directors of the Seventh Board of Directors", and elected non-employee representative directors of the company's seventh Board of Directors. On April 24, 2026, the company held an employee representative meeting and elected employee representative directors for the company's seventh board of directors.
The company held the first meeting of the seventh board of directors on May 14, 2026, and reviewed and approved the "Proposal on the Election of the Chairman of the Company", the "Proposal on the Election of Special Committee Members of the Company's Board of Directors", the "Proposal on the Appointment of the Company's General Manager", the "Proposal on the Appointment of the Company's Deputy General Manager", the "Proposal on the Appointment of the Company's Board Secretary", the "Proposal on the Appointment of the Company's Financial Director" and the "Proposal on the Appointment of the Company's Securities Affairs Representative". The chairman of the company's seventh board of directors and members of various special committees were elected, and the company agreed to appoint senior managers and securities affairs representatives. The relevant information is now announced as follows:
1. Composition of the seventh board of directors
Non-independent directors: Yao Bing (Chairman), Han Feng, Dai Long, Xu Wen
Independent directors: Di Congzhi, Yang Peng, Li Dibin, Zhou Jianping, Zhou Hong (effective after H shares are listed)
The company's seventh board of directors is composed of the above-mentioned nine directors, with a term of three years starting from the date of review and approval at the second extraordinary shareholders' meeting in 2026. Ms. Zhou Hong's term is from the date the company's H shares are issued and listed to the expiration date of the seventh board of directors' term. None of the above-mentioned persons has been punished by the China Securities Regulatory Commission and other relevant departments or punished by the stock exchange, and there is no violation of Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" The circumstances stipulated in Article 1 have not been disclosed by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the People's Court. Their qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association. The number of members of the company's board of directors who concurrently serve as senior managers of the company does not exceed one-half of the company's total directors; the proportion of independent directors meets the requirements of relevant laws and regulations, and their qualifications have been filed and reviewed by the Shenzhen Stock Exchange before the company's second extraordinary shareholders' meeting in 2026.
2. Composition of the special committees of the seventh session of the Board of Directors
The seventh session of the company's board of directors consists of the Strategy and ESG Committee, Audit Committee, Nomination Committee, and Remuneration and Appraisal Committee. The specific composition of the personnel is as follows:
Members of the Strategy and ESG Committee of the Board of Directors: Yao Bing (convener), Han Feng, and Li Dibin
Members of the Audit Committee of the Board of Directors: Di Congzhi (convener), Yang Peng, Zhou Jianping
Members of the Nomination Committee of the Board of Directors: Yang Peng (convener), Di Congzhi, Yao Bing
Members of the Remuneration and Appraisal Committee of the Board of Directors: Li Dibin (convener), Di Congzhi, Dai Long
3. Senior management personnel and securities affairs representatives
General Manager and Financial Director: Dai Long
Deputy General Manager: Hui Xiwu
Secretary of the Board of Directors and Securities Affairs Representative: Xu Wen
The Nomination Committee of the Company's Board of Directors reviewed and approved the appointment of senior management personnel. None of the above-mentioned senior managers have been punished by the China Securities Regulatory Commission and other relevant departments or punished by the stock exchange, and there is no violation of Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association. Xu Wen, the company’s board secretary and securities affairs representative, has obtained the board secretary qualification certificate issued by the Shenzhen Stock Exchange.
4. Contact information of the secretary of the board of directors and securities affairs representative
Position Secretary of the Board of Directors, Securities Affairs Representative
Name Xu Wen
Contact address: No. 62, Zhangju Road, Luancheng District, Shijiazhuang City, Hebei Province
Contact number 0311-67809843
Fax 0311-67809843
Email [email protected]
Announcement is hereby made.
Board of Directors of CSPC Innovation Pharmaceutical Co., Ltd.
May 14, 2026
Attachments:
- Resume of Mr. Yao Bing
Yao Bing: Male, Chinese nationality, no permanent residence abroad, born in May 1977, doctoral degree. He once worked for CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. and is currently the chairman of the company.
Mr. Yao Bing does not directly hold shares in the company. He is currently the executive director of CSPC Pharmaceutical Group Co., Ltd. and has no relationship with other directors and senior managers of the company. He does not exist in Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Mr. Han Feng
Han Feng: Male, Chinese nationality, no permanent residence abroad, born in August 1974, bachelor's degree. He once worked at the First Branch of Shijiazhuang No. 1 Pharmaceutical Factory and Shijiazhuang Pharmaceutical Group Xinnuowei Pharmaceutical Co., Ltd. He joined the company in April 2006 and served as workshop director, deputy general manager and general manager of the company, and is currently a director of the company.
Mr. Han Feng does not directly hold shares in the company. He is currently a director of CSPC Pharmaceutical Holdings Group Co., Ltd. and has no relationship with other directors and senior managers of the company. He does not exist in Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been disclosed by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets, or has been included in the list of persons subject to enforcement for untrustworthiness by the People's Court; his qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Mr. Dai Long
Dai Long: Male, Chinese nationality, no permanent residence abroad, born in June 1992, bachelor's degree. He once worked for CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. He joined the company in December 2016 and served as the company's financial manager, securities affairs representative, and secretary of the board of directors. Currently he is the director, general manager and financial director of the company.
Mr. Dai Long does not directly hold shares in the company; he has no relationship with shareholders, actual controllers who hold more than 5% of the company's shares, and other directors and senior managers of the company; he does not have Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Ms. Xu Wen
Xu Wen: Female, Chinese nationality, no permanent residence abroad, born in April 1990, master's degree. He once worked for Otsuka Pharmaceutical R&D (Beijing) Co., Ltd. He once served as senior director of the R&D Department and senior director of the Securities Affairs Department of CSPC Pharmaceutical Group Co., Ltd. He is currently a director and secretary of the board of directors of the company.
Ms. Xu Wen does not directly hold shares in the company; she has no relationship with shareholders who hold more than 5% of the company's shares, actual controllers, and other directors and senior managers of the company; she does not have Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Ms. Di Congzhi
Di Congzhi: Female, Chinese nationality, no permanent residence abroad, born in November 1975, doctoral degree, Chinese certified public accountant. Currently, he is the deputy dean, master's tutor and associate professor of the School of Accountancy of Hebei University of Economics and Business, and an independent director of Zhongyu Tiexin Technology Co., Ltd.
Ms. Di Congzhi does not directly hold shares in the company; she has no relationship with shareholders, actual controllers who hold more than 5% of the company's shares, and other directors and senior managers of the company; she does not have Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Mr. Li Dibin
Li Dibin: Male, Chinese nationality, no permanent residence abroad, born in March 1958, bachelor's degree. He once worked for China Advertising United Corporation, Xinhua News Agency, etc. Currently, he is the director of Zhongjianchuan (Beijing) Network Technology Co., Ltd. and the director and manager of Beijing Aikang Juntai International Medical Technology Co., Ltd.
Mr. Li Dibin does not directly hold shares in the company; he has no affiliation with shareholders, actual controllers who hold more than 5% of the company's shares, and other directors and senior managers of the company; he does not have Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Mr. Yang Peng
Yang Peng: Male, Chinese nationality, no permanent residence abroad, born in September 1971, master's degree, worked at China Paper Investment Corporation, China Reinsurance (Group) Co., Ltd., China Re Asset Management Co., Ltd., etc. Currently, he is an independent director of MCC Meiliyun Industrial Investment Co., Ltd. and an independent director of Zhengzhou Water Energy Saving Technology Co., Ltd.
Mr. Yang Peng does not directly hold shares in the company; he has no relationship with shareholders, actual controllers who hold more than 5% of the company's shares, and other directors and senior managers of the company; he does not have Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Mr. Zhou Jianping
Zhou Jianping: Male, Chinese nationality, no permanent residence abroad, born in September 1960, doctoral degree. He is currently a professor and doctoral supervisor of pharmacy at China Pharmaceutical University; a member of the National Pharmacopoeia Committee; chairman and executive director of the Pharmacy Department of Jiangsu Pharmaceutical Society and Nanjing Pharmaceutical Society; he won the Jiangsu Province Science and Technology Award and was awarded the title of Expert with Special Allowance from the State Council. Currently, he is an independent director of Anhui Shanhe Pharmaceutical Excipients Co., Ltd., an independent director of Suzhou Taolue Biotechnology Co., Ltd., and an independent director of Nanjing Haina Pharmaceutical Technology Co., Ltd.
Mr. Zhou Jianping does not directly hold shares in the company; he has no relationship with shareholders, actual controllers who hold more than 5% of the company's shares, and other directors and senior managers of the company; he does not have Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Mr. Hui Xiwu
Hui Xiwu: Male, Chinese nationality, no permanent residence abroad, born in September 1984, doctoral degree. He once worked for CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. He is currently a director of Wuhan Youzhiyou Biopharmaceutical Co., Ltd., president of the Research Institute of CSPC Jushi Biopharmaceutical Co., Ltd., and currently serves as deputy general manager of the company.
Mr. Hui Xiwu does not directly hold shares in the company; he has no relationship with shareholders who hold more than 5% of the company's shares, actual controllers, and other directors and senior managers of the company; he does not have Articles 3.2.3 and 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.
- Resume of Ms. Zhou Hong
Zhou Hong: Female, Chinese nationality, with permanent residence in Hong Kong, born in November 1962. He once served as the general manager of Nanming Co., Ltd. and currently serves as the executive director of Nanming Co., Ltd.
Ms. Zhou Hong does not directly hold shares in the company; she has no relationship with shareholders, actual controllers who hold more than 5% of the company's shares, and other directors and senior managers of the company; there is no Article 3.2.3, Article 3.2.4 of the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" Under the circumstances stipulated in the article, there is no situation that has been publicized by the China Securities Regulatory Commission on the public inquiry platform for illegal and untrustworthy information in the securities and futures markets or included in the list of persons subject to enforcement for untrustworthiness by the people's court. His qualifications are in compliance with the relevant laws and regulations such as the Company Law, normative documents and the relevant provisions of the Articles of Association.